Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have previously shown that humic acid (well-water humic acid, HA, and synthetic humic acid,
SHA
) enhances cell surface expression of tissue factor (TF). Here we report that incubation of human umbilical vein endothelial cells (HUVEC) for 2 hr with HA or
SHA
cause a rapid rise in TF mRNA levels, as shown by Northern blot analysis. To understand the cytotoxic and fibrinolytic effects of HA and
SHA
on cultured HUVEC, the cells treated with varying concentrations of HA and
SHA
for various periods of time. Both HA and
SHA
(10-200 micrograms/ml) inhibited the viability of subconfluent HUVEC, cultured in the presence or absence of 20% FBS (Fetal Bovine serum) in the culture medium, in a dose-dependent manner. Both HA and
SHA
induced surface changes in the HUVEC as revealed by scanning electron micrography (SEM). However, protocatechuic acid, the monomer of
SHA
, did not significantly inhibit cell growth, and showed a cytotoxic effect only at 200 micrograms/ml. Furthermore both HA and
SHA
stimulated HUVEC to produce plasminogen activator inhibitor (PAI-1) and
tissue plasminogen activator (t-PA)
in a dose and time dependent fashion; the amount of PAI-1 produced was found to exceed that of t-PA. The monomer of
SHA
did not have this stimulatory effect. These results distinctly suggest that in addition to the inhibition of viability HA is involved in TF induction and PAI-1 synthesis in HUVEC and these may be some of the plausible mechanisms underlying the thrombotic disorders in Blackfoot disease.
...
PMID:Effects of humic acid on the viability and coagulant properties of human umbilical vein endothelial cells. 861